Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (710)	2/4/1998 9:14:00 PM
From: READE SMITH	Read Replies (1) \| Respond to of 14101

Today's volume would suggest that word is out on -- Dimethaid's media release on the Feb. 14 presentation in Switzerland which will add to WF-10's credibility on both the Aids and Cancer fronts; Last month's quick response by the U.K to Dimethaid's Pennsaid application; This month's (routine) presentation to the U.K. Ministry of Health to clarify a few items; The greatly increased probability of fast-tracked U.K. Pennsaid approval by early spring; The potential for the U.S. and Canada to follow suit and approve Pennsaid rapidly.